Aide is a health technology company with a mission to make prescribed care as effective as possible. Our focus is on the unsustainable trajectory of healthcare utilisation caused by long-term conditions. This represents a challenge that costs the NHS £50bn and the US health system $1tr each year. Today, 70% of all primary and acute care spending is on long-term conditions.
Aide uses natural language to help improve self-care and clinical decision-making. Specifically, Aide is designed to address the rising human and economic cost of comorbidity: individuals with two or more long term conditions which presents more than 50% of the time. Aide is live in NHS England, supporting those with Asthma and Type 2 Diabetes.
Aide uses natural language to help improve self-care and clinical decision-making. Specifically, Aide is designed to address the rising human and economic cost of comorbidity: individuals with two or more long term conditions which presents more than 50% of the time. Aide is live in NHS England, supporting those with Asthma and Type 2 Diabetes.
Location: United Kingdom, England, London
Employees: 1-10
Total raised: $1.21M
Founded date: 2021
Investors 1
| Date | Name | Website |
| 11.11.2022 | Fuel Ventu... | fuel.ventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.11.2022 | Pre-Seed | $1.21M | - |
Mentions in press and media 3
| Date | Title | Description |
| 25.11.2022 | Aide Health Raises £1M in Pre-Seed Funding | Aide Health, a London, UK-based health-tech startup, raised £1M in Pre-Seed funding. The round was led by Hambro Perks through its EIS fund, with participation from Fuel Ventures, 1818 Ventures and APX Ventures. The company intends to use t... |
| 15.11.2022 | Aide Health: platform trialled by NHS gets £1m cash injection | Remote health platform Aide Health has secured $1.2m (£1m) in pre-seed capital, in a round led by Hambro Perks’ EIS fund. Medical professionals can use Aide Health’s platform to remotely monitor patients with chronic diseases such as type-2... |
| 15.11.2022 | Hambro Perks leads Aide's $1.2 million pre-seed for long-term illness digital care app | London-based digital health app startup Aide Health just raised $1.2 million in pre-seed funds to bring its digital platform for managing long-term health conditions to more UK patients and their clinicians. The round is led by global inves... |